These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16908371)

  • 1. Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
    Falagas ME; Angelousi AG; Peppas G
    J Am Acad Dermatol; 2006 Sep; 55(3):537-8. PubMed ID: 16908371
    [No Abstract]   [Full Text] [Related]  

  • 2. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is imiquimod effective and safe for actinic keratosis?
    Walker JK; Koenig C
    J Fam Pract; 2003 Mar; 52(3):184-5. PubMed ID: 12620165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of actinic keratosis studies with imiquimod 5% cream.
    Tran H; Chen K; Shumack S
    Br J Dermatol; 2003 Nov; 149 Suppl 66():37-9. PubMed ID: 14616347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
    Gupta AK; Davey V; Mcphail H
    J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study.
    Stockfleth E; Christophers E; Benninghoff B; Sterry W
    Arch Dermatol; 2004 Dec; 140(12):1542. PubMed ID: 15611446
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses.
    D'Addario S; Carrington PR
    Acta Derm Venereol; 2006; 86(4):366-7. PubMed ID: 16874431
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of non-melanoma skin cancer: immunotherapy as a viable option.
    Shumack S; Rigel D
    Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):18-22. PubMed ID: 14606278
    [No Abstract]   [Full Text] [Related]  

  • 10. From a new vision of actinic keratosis to imiquimod 3.75%, the new treatment standard. Introduction.
    Stockfleth E
    J Eur Acad Dermatol Venereol; 2015 Jan; 29 Suppl 1():1-2. PubMed ID: 25470717
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating actinic keratoses with imiquimod.
    Dixon A
    Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imiquimod (Aldara) for actinic keratoses.
    Med Lett Drugs Ther; 2004 May; 46(1183):42-4. PubMed ID: 15159659
    [No Abstract]   [Full Text] [Related]  

  • 13. Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
    Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
    Br J Dermatol; 2007 Dec; 157(6):1132-47. PubMed ID: 17944981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatoscopy for monitoring treatment of actinic keratosis with imiquimod.
    Kaçar N; Sanli B; Zalaudek I; Yildiz N; Ergin S
    Clin Exp Dermatol; 2012 Jul; 37(5):567-9. PubMed ID: 22300301
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on actinic keratosis in clinical trial experience with imiquimod.
    Ferrándiz C
    Br J Dermatol; 2007 Dec; 157 Suppl 2():32-3. PubMed ID: 18067629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and emerging treatments for nonmelanomas and actinic keratoses.
    Peterson SR; Goldberg LH
    J Drugs Dermatol; 2003 Aug; 2(4):429-32. PubMed ID: 12884470
    [No Abstract]   [Full Text] [Related]  

  • 17. Imiquimod for actinic keratosis: systematic review and meta-analysis.
    Hadley G; Derry S; Moore RA
    J Invest Dermatol; 2006 Jun; 126(6):1251-5. PubMed ID: 16557235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and emerging topical approaches for actinic keratoses.
    Del Rosso JQ
    Cutis; 2003 Oct; 72(4):273-6, 279. PubMed ID: 14604078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zyclara (imiquimod) cream, 3.75%.
    Gupta AK; Cooper EA; Abramovits W
    Skinmed; 2010; 8(4):227-9. PubMed ID: 21137610
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.